| Company Name: |
BOC Sciences |
| Tel: |
+1-631-485-4226 |
| Email: |
inquiry@bocsci.com |
Benzeneacetamide, 4-(aminosulfonyl)-N-[3-cyano-5-(cyclohexylmethyl)-4,5,6,7-tetrahydro-6,6-dimethylthieno[3,2-c]pyridin-2-yl]- manufacturers
- NITD-688
-
- $5790.00
-
2026-07-21
- CAS:2407227-31-8
- Purity: 99.93%
- Supply Ability: 10g
|
| | Benzeneacetamide, 4-(aminosulfonyl)-N-[3-cyano-5-(cyclohexylmethyl)-4,5,6,7-tetrahydro-6,6-dimethylthieno[3,2-c]pyridin-2-yl]- Basic information |
| Product Name: | Benzeneacetamide, 4-(aminosulfonyl)-N-[3-cyano-5-(cyclohexylmethyl)-4,5,6,7-tetrahydro-6,6-dimethylthieno[3,2-c]pyridin-2-yl]- | | Synonyms: | Benzeneacetamide, 4-(aminosulfonyl)-N-[3-cyano-5-(cyclohexylmethyl)-4,5,6,7-tetrahydro-6,6-dimethylthieno[3,2-c]pyridin-2-yl]-;N-(3-Cyano-5-(cyclohexylmethyl)-6,6-dimethyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)-2-(4-sulfamoylphenyl)acetamide;NITD-688 | | CAS: | 2407227-31-8 | | MF: | C25H32N4O3S2 | | MW: | 500.68 | | EINECS: | | | Product Categories: | | | Mol File: | 2407227-31-8.mol | ![Benzeneacetamide, 4-(aminosulfonyl)-N-[3-cyano-5-(cyclohexylmethyl)-4,5,6,7-tetrahydro-6,6-dimethylthieno[3,2-c]pyridin-2-yl]- Structure](CAS/20210305/GIF/2407227-31-8.gif) |
| | Benzeneacetamide, 4-(aminosulfonyl)-N-[3-cyano-5-(cyclohexylmethyl)-4,5,6,7-tetrahydro-6,6-dimethylthieno[3,2-c]pyridin-2-yl]- Chemical Properties |
| density | 1.34±0.1 g/cm3(Predicted) | | pka | 10.06±0.10(Predicted) | | form | Solid | | color | White to off-white |
| | Benzeneacetamide, 4-(aminosulfonyl)-N-[3-cyano-5-(cyclohexylmethyl)-4,5,6,7-tetrahydro-6,6-dimethylthieno[3,2-c]pyridin-2-yl]- Usage And Synthesis |
| Uses | NITD-688 is an orally active pan-serotype inhibitor of the dengue virus NS4B protein. NITD-688 can be used in the research of dengue virus (DENV)[1]. | | in vivo | NITD-688 (30 mg/kg, oral gavage, twice daily for 3 days) demonstrates excellent antiviral efficacy in infected AG129 mice[1].
NITD-688 (15-300 mg/kg, oral gavage, per day for 7 days) is well tolerated in rats and dogs (toxicology studies)[1].
| Animal Model: | Infected AG129 mice[1] | | Dosage: | 30 mg/kg | | Administration: | Oral gavage, twice daily for 3 days | | Result: | Resulted in a 1.16-log reduction in viremia. |
| | References | [1] Moquin SA, et al. NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models. Sci Transl Med. 2021 Feb 3;13(579):eabb2181. DOI:10.1126/scitranslmed.abb2181 |
| | Benzeneacetamide, 4-(aminosulfonyl)-N-[3-cyano-5-(cyclohexylmethyl)-4,5,6,7-tetrahydro-6,6-dimethylthieno[3,2-c]pyridin-2-yl]- Preparation Products And Raw materials |
|